More ACTIONS needed to reach a consensus on adjunctive antidepressant therapy for negative symptoms of schizophrenia -- Akhondzadeh and Moazen-Zadeh 20 (1): e3 -- Evidence-Based Mental Health
Persistent negative symptoms which do not respond to antipsychotic regimens are experienced by 15–20% of patients with schizophrenia.1 Antidepressants have been the most studied augmentation strategy in these patients;2 however, previous findings are inconsistent in terms of their potential benefits. To read the full article, log in using your NHS OpenAthens details.
